CD8A and cancer: This association with poor prognosis may be suggested by PD-L1/PD-1 binding to suppress CD8+ cytotoxic T-lymphocyte activation, leading to the evasion of the host immune anti-tumour response, thereby decreasing the survival rate in many cancers (37, 75).